Chlamydial and Gonococcal Genital Infections: A Narrative Review

Area of Science:

• Microbiology
• Infectious Diseases
• Public Health

Background:

• Sexually transmitted infections (STIs) represent a major global health burden, causing significant morbidity and mortality.
• Chlamydial infections (CT) and gonococcal infections (NG) are the most prevalent bacterial STIs, often asymptomatic but leading to severe long-term complications.
• Co-infection is common, and symptoms overlap, necessitating a dual-testing approach.

Purpose of the Study:

• To review the clinical aspects, diagnostics, and treatments for CT and NG infections.
• To address cost-effective control strategies for these widespread STIs.
• To explore the molecular basis of CT and NG infections for future therapeutic and vaccine development.

Main Methods:

• Review of current literature on CT and NG infections.
• Analysis of diagnostic testing strategies, including dual-testing.
• Evaluation of antibiotic treatment efficacy and challenges, including resistance.
• Discussion of molecular mechanisms and potential for novel interventions.

Main Results:

• CT and NG infections require prompt diagnosis and treatment, with dual testing recommended due to overlapping symptoms and co-occurrence.
• Antibiotic therapy is standard, but rising antibiotic resistance, especially in NG, complicates effective control.
• Understanding molecular mechanisms is key to developing new drugs and vaccines.

Conclusions:

• Effective control of CT and NG infections necessitates integrated strategies encompassing diagnostics, treatment, and prevention.
• Addressing antibiotic resistance is paramount for managing gonococcal infections.
• Further research into molecular pathways may yield novel interventions, including vaccines, to combat these prevalent STIs.